Physician

Samuel Evan Day, MD, PHD

According to 2025 Medicare claims, Samuel Day, MD, PHD (NPI: 1811304652) practices radiation oncology in the Tucson, AZ market, with the plurality of this provider's patient population coming from Pima, AZ. This provider's primary affiliated billing organization is ARIZONA BLOOD AND CANCER SPECIALISTS, PLLC (NPI: 1093370918; TIN: 834425637) and primary practice location at 85716-1729. Day is affiliated with the Innovation Care Partners MSSP (ACO ID: A2029) and ABC Network (ACO ID: A5554), participating under the MSSP model.

Day's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 503 traditional Medicare patients, billed 20,075 HCPCS/CPT codes, and received $2,041,216 in Medicare payments. The top billing code was 78815 (Nuclear medicine study from skull base to mid-thigh with ct scan). Part D data shows 136 prescription claims across 65 beneficiaries totaling $25,269 in drug costs, led by Dexamethasone (Dexamethasone). Open Payments data shows 38 records totaling $871. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $238,052 to $2,041,216. Similarly, Part D prescription costs have risen steadily, from $2,752 to $25,269. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.0M$2.0M2019 Medicare payment: $238,052 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $749,091 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $617,716 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,515,712 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,690,367 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,041,216 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019971,120$238,052
20202533,538$749,091
20212914,154$617,716
202245123,279$1,515,712
202346220,165$1,690,367
202450320,075$2,041,216

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$13K$25K2015 Drug cost: $2,752 (USD; Tot_Drug_Cst)2016 Drug cost: $826 (USD; Tot_Drug_Cst)2017 Drug cost: $1,452 (USD; Tot_Drug_Cst)2018 Drug cost: $208 (USD; Tot_Drug_Cst)2019 Drug cost: $662 (USD; Tot_Drug_Cst)2020 Drug cost: $2,125 (USD; Tot_Drug_Cst)2021 Drug cost: $1,140 (USD; Tot_Drug_Cst)2022 Drug cost: $1,978 (USD; Tot_Drug_Cst)2023 Drug cost: $20,604 (USD; Tot_Drug_Cst)2024 Drug cost: $25,269 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152149$2,752
20162654$826
20171226$1,452
2018N/R12$208
2019N/R18$662
20204795$2,125
20213768$1,140
202260109$1,978
202376147$20,604
202465136$25,269

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
78815Nuclear medicine study from skull base to mid-thigh with ct scan156180$1,232
A9552Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries145169$282
G6015Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session1201,201$270
77334Design and construction of complex radiation treatment device111165$95
77014Ct guidance for insertion of radiation therapy fields1251,195$91

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
DexamethasoneDexamethasone15299$319
Tamsulosin HclTamsulosin Hcl331,950$146
Ciprofloxacin HclCiprofloxacin Hcl2464$68

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.38$871Merck Sharp & Dohme LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Samuel Evan Day, MD, PHD?

Tedicare shows public-source Medicare data for Samuel Evan Day, MD, PHD (NPI 1811304652), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Samuel Evan Day, MD, PHD have ACO affiliation data?

Samuel Evan Day, MD, PHD is shown with ACO affiliation data for Innovation Care Partners MSSP (MSSP, ACO ID A2029) and ABC Network (MSSP, ACO ID A5554).

What billing organization is linked to Samuel Evan Day, MD, PHD?

Samuel Evan Day, MD, PHD is linked to ARIZONA BLOOD AND CANCER SPECIALISTS, PLLC (billing NPI 1093370918) in the available physician profile data.

Does Samuel Evan Day, MD, PHD have Open Payments data?

Samuel Evan Day, MD, PHD has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.